Invention Application
- Patent Title: DEXTROMETHORPHAN AND GUAIFENESIN SYRUP FORMULATION OR SUSPENSION
-
Application No.: US17821134Application Date: 2022-08-19
-
Publication No.: US20220387598A1Publication Date: 2022-12-08
- Inventor: Max Spielberg , David Johnson
- Applicant: Genexa Inc.
- Applicant Address: US GA Atlanta
- Assignee: Genexa Inc.
- Current Assignee: Genexa Inc.
- Current Assignee Address: US GA Atlanta
- Main IPC: A61K47/46
- IPC: A61K47/46 ; A61K9/00 ; A61K36/88 ; A61K35/644 ; A61K36/736 ; A61K36/35 ; A61P11/14 ; A61K36/235 ; A61K47/26 ; A61K36/9068 ; A61K47/12 ; A61K36/9066 ; A61K36/074 ; A61K31/167
Abstract:
A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
Public/Granted literature
- US11931413B2 Dextromethorphan and guaifenesin syrup formulation or suspension Public/Granted day:2024-03-19
Information query
